Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.4/5
Kronos Bio (KRON US)
Watchlist
14
Analysis
Health Care
•
United States
Kronos Bio, Inc. operates as a biotechnology company. The Company discovers and develops therapies that modulate historically recalcitrant cancer targets. Kronos Bio serves customers in worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Kronos Bio
•
09 Oct 2020 09:36
Kronos Bio IPO. Gilead’s SYK Inhibitor Portfolio Will Boost The Pipeline
A clinical-stage biotech company Kronos Bio, founded by partners and executives from Two River Group, priced its IPO of ~13.1 million shares at...
Andrei Zakharov
Follow
499 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.9
x